STOCK TITAN

Myomo (NYSE: MYO) details 2026 executive salary-for-RSU compensation plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Myomo, Inc. disclosed that its Compensation Committee approved a 2026 salary-for-restricted stock unit program open to all salaried employees. CEO Paul Gudonis and CFO David Henry each voluntarily elected to reduce their 2026 base salary by 10% in exchange for RSUs with an aggregate grant date fair value equal to 115% of the salary foregone, or $40,000 for the CEO and $30,000 for the CFO.

The company may, in its sole discretion, terminate or modify this program at any time before January 12, 2026; if it does, no RSUs will be granted and base salaries will remain unchanged. Subject to that right, RSUs will be granted in equal quarterly installments beginning January 12, 2026, with each quarterly grant vesting in full three months after its grant date under the company’s 2018 Stock Option and Incentive Plan and the applicable RSU agreements, provided the officer remains in continuous service.

Positive

  • None.

Negative

  • None.
0001369290false00013692902025-12-102025-12-10

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 10, 2025

Myomo, Inc.

(Exact Name of Company as Specified in Charter)

 

 

 

 

 

Delaware

 

001-38109

 

47-0944526

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

 

45 Blue Sky Dr., Suite 101

Burlington, MA

 

01803

(Address of Principal Executive Offices)

 

(Zip Code)

Company’s telephone number, including area code: (617) 996-9058

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

 

 

 

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.0001 par value per share

 

MYO

 

NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


 

 

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment
of Principal Officers

On December 10, 2025, the Compensation Committee of the Board of Directors of Myomo, Inc. (the “Company”) approved a salary-for-restricted stock units (“RSUs”) program open to all salaried employees pursuant to which (i) Paul Gudonis, the Company’s Chief Executive Officer, voluntarily elected to reduce his base salary for 2026 by 10% in exchange for RSUs with an aggregate grant date fair value equal to 115% of the amount of salary foregone ($40,000), and (ii) David Henry, the Chief Financial Officer of the Company, voluntarily elected to reduce his base salary for 2026 by 10% in exchange for RSUs with an aggregate grant date fair value equal to 115% of the amount of salary foregone ($30,000). The Company retains the right, in its sole discretion, to terminate or modify the salary-for-RSU program at any time prior to January 12, 2026 (the “Initial Grant Date”). If the Company exercises this termination right, no RSU grants will be made, and the officers’ base salaries will remain unchanged.

Subject to the Company’s right to terminate or modify the program prior to the Initial Grant Date, all such RSUs will be granted in equal quarterly installments, beginning on January 12, 2026. Each quarterly RSU grant will vest in full on the three-month anniversary of the grant date in accordance with the terms and conditions of the Company’s 2018 Stock Option and Incentive Plan, as may be amended, and the applicable restricted stock unit agreements, subject to the officer’s continuous service with the Company through each applicable date.

 

Item 9.01.

(d) Exhibits

Exhibit No.

 

Description

 

 

 

104

 

The cover page from the Company’s Form 8-K dated December 16, 2025, formatted in Inline XBRL

 

 

 

 

 


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

MYOMO, INC.

 

 

 

 

Date:

December 16, 2025

By:

/s/ David A. Henry

 

 

 

David A. Henry
Chief Financial Officer

 


FAQ

What executive compensation change did Myomo (MYO) disclose in this 8-K?

Myomo disclosed that its Compensation Committee approved a 2026 salary-for-restricted stock unit program under which CEO Paul Gudonis and CFO David Henry each voluntarily elected to reduce their 2026 base salaries by 10% in exchange for RSUs.

How much salary will Myomoe28099s CEO and CFO exchange for RSUs in 2026?

Under the program, CEO Paul Gudonis will forgo salary in exchange for RSUs with an aggregate grant date fair value of $40,000, and CFO David Henry will receive RSUs with an aggregate grant date fair value of $30,000, each equal to 115% of the salary foregone.

Can Myomo (MYO) change or cancel the 2026 salary-for-RSU program?

Yes. Myomo retains the right, in its sole discretion, to terminate or modify the salary-for-RSU program at any time before January 12, 2026. If it exercises this right, no RSU grants will be made and the officerse28099 base salaries will remain unchanged.

When will the RSUs granted to Myomo executives start and how do they vest?

Subject to the company not terminating or modifying the program, RSUs will be granted in equal quarterly installments beginning on January 12, 2026. Each quarterly RSU grant will vest in full three months after its grant date, subject to the officere28099s continuous service with Myomo.

Who is eligible for Myomoe28099s 2026 salary-for-RSU program?

The 2026 salary-for-restricted stock unit program approved by the Compensation Committee is described as being open to all salaried employees, with specific elections disclosed for the CEO and CFO.

Under what plan will the new RSUs for Myomo (MYO) executives be issued?

The RSUs to be granted under the 2026 salary-for-RSU program will be issued in accordance with the terms and conditions of Myomoe28099s 2018 Stock Option and Incentive Plan, as may be amended, and the applicable restricted stock unit agreements.

Myomo

NYSE:MYO

MYO Rankings

MYO Latest News

MYO Latest SEC Filings

MYO Stock Data

38.44M
35.62M
6.99%
66.68%
3.84%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
BOSTON